Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

Journal of the American College of Cardiology

Volumn 51, Issue 11, 2008, Pages 1124-1125

  Nakazawa, Gaku ^a   Cheng, Qi ^a   Xu, Xin ^a   Finn, Aloke V ^a   Kolodgie, Frank D ^a   Virmani, Renu ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYTOKINE; EVEROLIMUS; METAL; RAPAMYCIN; RNA; VASCULOTROPIN;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CLINICAL STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG ELUTING STENT; DRUG IMPLANTATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HEART FUNCTION; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIAL INFARCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTION; VASODILATION; VASOMOTOR SYSTEM;

EID: 40649125580     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.055     Document Type: Letter

References (5)

1. Obata J.E., Kitta Y., Takano H., et al. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 50 (2007) 1305-1309
2. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
3. Togni M., Windecker S., Cocchia R., et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46 (2005) 231-236
4. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
5. Wysocki S.J., Zheng M.H., Smith A., and Norman P.E. Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig. Eur J Vasc Endovasc Surg 15 (1998) 225-230